|SEQ_NO||1||Date of announcement||2020/11/10||Time of announcement||14:56:45|
|Subject||Announcement of TTY Biopharm's unaudited income information in October 2020|
|Date of events||2020/11/10||To which item it meets||paragraph 53|
|Statement||1.Date of occurrence of the event:2020/11/10
2.Company name:TTY Biopharm Co., Ltd.
3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office
4.Reciprocal shareholding ratios:N/A
5.Cause of occurrence:TTY Biopharm posted a consolidated net sales of $516,592 thousands(expressed in NT dollars; unaudited), a consolidated operating profit of $118,810 thousands, and a consolidated income before tax of $120,277 thousands in October 2020; net income attributed to stockholders of the company was $83,048 thousands; EPS is $0.33.
Year-to-date consolidated net sales was $3,535,598 thousands (in NT dollars; unaudited), a consolidated operating profit was $832,696 thousands and consolidated income before tax was $990,956 thousands until October 2020; year-to-date net income attributed to stockholders of the company was $744,611 thousands; EPS is $2.99.
7.Any other matters that need to be specified:The numbers above are unaudited. In term of the final net sales and profits, quarterly financial reports audited by independent accountants will prevail.